All Articles

By monetizing empty lots while securing spots for their own drivers, trucking firms are using a new marketplace model to solve a national parking crisis.

Pomeroy's new ELERA® certification isn't just a partnership update. It’s a strategic play to solve retail’s biggest AI implementation headaches.

Genasys extends its loan maturity, but at a steep price: a 20% guaranteed return for its lender. Is this a savvy move to fuel growth or a risky bet?

JBT Bancorp's stunning first-half earnings reveal more than just numbers. It's a story of shrewd interest margin management and innovative niche markets.

A multi-billion dollar acquisition reunites a CEO with his roots. This is no nostalgia play; it's a calculated move to dominate a changing industry.

Terret unveils Nexus, an AI platform that promises not just to find sales problems, but to fix them. Is this the dawn of the autonomous revenue engine?

A new integration between Rogo and Snowflake solves the biggest AI problem for finance: using proprietary data without compromising security or governance.

As AI-powered crime surges, Alloy reports major growth by deploying autonomous "agentic AI" to continuously vet customers and automate compliance work.

With a $2M NIH grant, a San Diego biotech is using AI to find the 'on switches' in our DNA, a breakthrough that could make future therapies more potent.

A new fund aims to fix our strained power grid. But can private capital alone solve a crisis fueled by AI and EVs, or is this just a new gold rush?

A new deal between Goody, Wet Brush, and a youth softball league shows a shift in sponsorship—investing in athlete confidence, not just brand visibility.

A new report argues static multicultural segments are obsolete. As consumers 'code-switch' identities, AI-driven cultural intelligence is becoming the key to relevance.

Slate Medicines appoints Mark W. Hahn, a CFO known for steering biotechs to massive acquisitions, signaling a major strategic push for its next-gen therapy.

With a Parkinson's therapy in hand and a universal AI model, Cellular Intelligence adds seasoned leaders to turn biological ambition into durable value.

A construction firm's radical shift to critical minerals, guided by a military strategist, reveals a new front in the race for America's resource security.

After a 90% stock crash since its IPO, activist firm Randian Capital is demanding a strategic review, questioning leadership and industry headwinds.

As Corrixr's novel CRISPR therapy nears human trials, the appointment of Seagen veteran Nancy Whiting signals a strategic shift from lab to market.

As cyber threats escalate, one company's record growth reveals a market shift: CISOs no longer want more data; they need smarter answers. Here's the why.

A new partnership embeds discounted pet insurance into leasing software, signaling a shift from simple pet tolerance to strategic, tech-driven resident support.

Yellowstone Bourbon’s 2026 release blends 14-year-old bourbon with a dual-port cask finish, targeting collectors and conscious consumers alike.